SCHEMBL20288103

SCHEMBL20288103

Cc1cccc(-c2cc(C)cnc2N)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 2/20 0.57
▸ ADORA1 P30542 2/20 0.53
▸ MAP4K4 O95819 4/20 0.49
▸ FYN P06241 4/20 0.49
▸ CHEK1 O14757 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ NTRK1 P04629 1/20 0.49
▸ LCK P06239 1/20 0.49
▸ CSF1R P07333 1/20 0.49
▸ MET P08581 1/20 0.49
▸ PDGFRB P09619 1/20 0.49
▸ PIM1 P11309 1/20 0.49
▸ FGFR1 P11362 1/20 0.49
▸ PDGFRA P16234 1/20 0.49
▸ PRKACA P17612 1/20 0.49
▸ LTK P29376 1/20 0.49
▸ GRK5 P34947 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ MAPK8 P45983 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4412551 0.85 CYP2A6 (0.60) CYP2A6ADORA1MAP4K4FYNFGFR1
SCHEMBL29857982 0.85 ADORA1 (0.49) CYP2A6ADORA1MAP4K4FYNCHEK1
SCHEMBL12516853 0.85 ADORA1 (0.49) CYP2A6ADORA1MAP4K4FYNCHEK1
SCHEMBL4582434 0.85 ADORA1 (0.49) CYP2A6ADORA1MAP4K4FYNCHEK1
SCHEMBL27227708 0.84 PDGFRB (0.50) CYP2A6ADORA1MAP4K4FYNCHEK1
SCHEMBL3458331 0.81 ADORA2A (0.52) CYP2A6ADORA1RAB9ANPC1ADORA2A
SCHEMBL6069433 0.80 RIPK2 (0.50) CYP2A6MAP4K4FYNABL1CSF1R
SCHEMBL12518227 0.79 CYP2A6 (0.62) CYP2A6MAP4K4FYNLRRK2RAB9A
SCHEMBL4582784 0.79 MAP4K4 (0.69) ADORA1MAP4K4FYNCHEK1ABL1
SCHEMBL30488016 0.76 ADORA1 (0.70) ADORA1MAP4K4FYNCHEK1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018108156-A1 ROCK INHIBITOR AND APPLICATION THEREOF 成都先导药物开发有限公司 2018-06-21 — — WO disclosed
Send feedback